The World Health Organization (WHO) has dismissed widespread concerns suggesting that paracetamol use during pregnancy could cause autism in children. The global health body reaffirmed that there is no scientific evidence establishing a direct link between the commonly used pain reliever and neurodevelopmental disorders, stressing that paracetamol remains safe when used appropriately under medical guidance.
In recent years, fears have circulated from studies and online debates alleging that prenatal exposure to paracetamol might be associated with conditions such as autism and attention deficit hyperactivity disorder (ADHD). These claims have caused confusion among expectant mothers, with some becoming anxious about using the drug for pain relief or fever management during pregnancy. However, WHO has clarified that such concerns are not supported by conclusive scientific research.
According to WHO experts, paracetamol, also known as acetaminophen, is widely regarded as one of the safest medications for managing pain and reducing fever during pregnancy. The agency emphasized that its decades-long monitoring of clinical data shows no consistent evidence linking the drug to long-term developmental issues in children. They noted that misleading interpretations of inconclusive studies have been a major driver of public concern.
Health specialists also highlighted the risks of untreated high fever or unmanaged pain in pregnant women, which can pose more danger to both mother and baby than the controlled use of paracetamol. WHO urged healthcare providers to reassure patients, stressing that the benefits of appropriate paracetamol use far outweigh any hypothetical risks being circulated without solid proof.
While WHO encouraged further scientific studies on maternal health and child development, it reiterated that pregnant women should not be discouraged from using paracetamol when necessary and in recommended doses. The organization cautioned against self-medication and called on expectant mothers to always consult healthcare professionals before taking any drug.
Public health experts have welcomed WHO’s clarification, describing it as timely amid rising misinformation about pregnancy care. They warned that the spread of unverified claims can fuel unnecessary fear, leading women to avoid safe treatments and potentially endangering maternal and child health.
WHO’s latest stance aligns with the positions of other global health regulators, including the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA), which also maintain that paracetamol remains a safe and effective medication for pregnant women when used responsibly.
